USD 6.77 billion
Report ID:
SQMIG35B2152 |
Region:
Global |
Published Date: February, 2025
Pages:
219
|Tables:
63
|Figures:
75
Vaccine Delivery Devices Market size was valued at USD 6.77 billion in 2023 and is poised to grow from USD 7.33 billion in 2024 to USD 13.88 billion by 2032, growing at a CAGR of 8.3% during the forecast period (2025-2032).
The global vaccine delivery devices market is witnessing significant growth due to increasing vaccination efforts and the need for efficient administration.
Key factors such as expanding immunization programs, advancements in needle technologies, and rising awareness about preventive healthcare drive market expansion.
Maintaining the integrity of vaccines through proper temperature control during storage and transportation, known as the cold chain, remained a significant concern.
Innovations in vaccine delivery devices aimed to ensure that vaccines could be transported and stored under appropriate conditions, especially in regions with limited access to reliable refrigeration infrastructure.
Developments in temperature-stable formulations and packaging solutions helped extend the reach of vaccines to remote areas.
Auto-disable syringes, safety needles, and prefilled syringe systems are gaining traction to ensure safe and accurate vaccine delivery.
Geographically, North America and Europe dominate the market, but Asia-Pacific exhibits promising potential. As demand for vaccines rises, the market is expected to further evolve with a focus on innovative, user-friendly, and cost-effective delivery solutions.
US Vaccine Delivery Devices Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
USD 6.77 billion
Largest Segment
syringes
Fastest Growth
jet injectors
Growth Rate
8.3% CAGR
To get more reports on the above market click here to Buy The Report
Global Vaccine Delivery Devices Market is segmented by Type of Device, Route of Administration, End Users and region. Based on Type of Device, the market is segmented into Needle-Free Injection Systems, Oral Delivery Systems, Nasal Delivery Systems, Jet Injectors, Microneedle Patches and Microinjectors. Based on Route of Administration, the market is segmented into Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination and Other Vaccinations. Based on End Users, the market is segmented into Hospitals, Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Hospitals & Clinics were likely the largest end-user segment for vaccine delivery devices. These settings are critical for routine immunizations, emergency vaccinations, and mass vaccination campaigns.
Homecare Settings might have been one of the fastest-growing segments. The demand for self-administered vaccines and the convenience of receiving vaccinations at home could have driven the growth of this segment.
The largest segment in the vaccine delivery devices market is traditional syringes. They have been the primary method for vaccine administration for many years and are widely used globally. However, there has been a growing interest in newer, more advanced devices due to factors such as patient comfort, safety, and ease of use.
The fastest-growing segments in the vaccine delivery devices market were likely the needle-free injectors and autoinjectors. These segments were gaining traction due to their advantages in terms of reducing the fear of injections, minimizing needle stick injuries, and enabling self-administration for certain vaccines.
To get detailed analysis on other segments, Request For Free Sample Report
The largest application segment for activated carbon fibers has historically been air purification. With increasing concerns about indoor air quality and pollution, the demand for air purification systems that utilize activated carbon fibers for effective VOC and odor removal has been on the rise.
The fastest-growing application segment can vary depending on trends and technological advancements. Water treatment has shown potential for significant growth due to increasing awareness of water pollution and the need for clean water sources. Additionally, the medical and healthcare sector could also experience growth as researchers explore innovative ways to use activated carbon fibers in drug delivery systems and wound care applications.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing Vaccine Demand
Technological Advancements
High Costs
Regulatory Challenges
Request Free Customization of this report to help us to meet your business objectives.
The global vaccine delivery devices market features intense competition among prominent players, including BD (Becton, Dickinson and Company), Gerresheimer AG, West Pharmaceutical Services, Inc., and Schott AG. These industry leaders continually innovate and diversify their product portfolios, offering a wide range of advanced and user-friendly devices such as syringes, auto-injectors, and needle-free injectors. Emphasis on technological advancements, safety, and precision drives this competition, aimed at capturing larger market shares and meeting the growing demand for efficient vaccine administration worldwide. Additionally, collaborations, acquisitions, and strategic partnerships are common strategies employed to enhance global market presence and capitalize on emerging opportunities.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our analysis, the global vaccine delivery devices market is poised for promising growth as the world prioritizes immunization against various diseases. With the ongoing development of advanced delivery technologies, including needle-free injectors, microneedle patches, and wearable devices, the market is set to witness increased efficiency, reduced pain, and improved accessibility to vaccines. Rising global health awareness, government initiatives, and expanding vaccination programs will further drive demand. However, challenges related to distribution infrastructure in remote areas and cost concerns may impact adoption. Overall, the market's future holds potential for innovation and collaboration to ensure widespread, effective vaccine administration.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 6.77 billion |
Market size value in 2032 | USD 13.88 billion |
Growth Rate | 8.3% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Vaccine Delivery Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Vaccine Delivery Devices Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Vaccine Delivery Devices Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Vaccine Delivery Devices Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
Vaccine Delivery Devices Market size was valued at USD 5.76 Billion in 2023 and is poised to grow from USD 6.22 Billion in 2024 to USD 11.59 Billion by 2032, growing at a CAGR of 8.07% during the forecast period (2025-2032).
The global vaccine delivery devices market features intense competition among prominent players, including BD (Becton, Dickinson and Company), Gerresheimer AG, West Pharmaceutical Services, Inc., and Schott AG. These industry leaders continually innovate and diversify their product portfolios, offering a wide range of advanced and user-friendly devices such as syringes, auto-injectors, and needle-free injectors. Emphasis on technological advancements, safety, and precision drives this competition, aimed at capturing larger market shares and meeting the growing demand for efficient vaccine administration worldwide. Additionally, collaborations, acquisitions, and strategic partnerships are common strategies employed to enhance global market presence and capitalize on emerging opportunities. 'BD (Becton, Dickinson and Company) - USA', 'Gerresheimer AG - Germany', 'SCHOTT AG - Germany', 'West Pharmaceutical Services, Inc. - USA', 'Terumo Corporation - Japan', 'Vetter Pharma International GmbH - Germany', 'Nipro Corporation - Japan', 'Weigao Group - China', 'Sulzer Ltd. - Switzerland', 'Ypsomed AG - Switzerland', 'Stevanato Group - Italy', 'Catalent, Inc. - USA', 'Ompi (Stevanato Group) - Italy', 'SCHOTT AG - Germany', 'Elcam Medical - Israel', 'AptarGroup, Inc. - USA', 'Datwyler Group - Switzerland', 'Sandoz International GmbH - Switzerland', 'Ciron Drugs & Pharmaceuticals Pvt. Ltd. - India', 'Shandong Weigao Group Medical Polymer Co., Ltd. - China'
The demand for vaccines has been on the rise due to the ongoing efforts to combat infectious diseases, such as COVID-19 and other preventable illnesses. This demand drives the need for efficient and effective vaccine delivery devices to ensure proper immunization.
Innovations in Needle-Free Delivery Systems: The development and adoption of needle-free vaccine delivery systems were gaining momentum. These systems aim to minimize needle-related anxieties and improve patient compliance by delivering vaccines through alternative methods such as jet injectors, microneedle patches, and nasal sprays. These technologies offer the potential to reduce the risk of needle-stick injuries, improve vaccine stability, and enhance the efficiency of vaccination campaigns.
The largest application segment for activated carbon fibers has historically been air purification. With increasing concerns about indoor air quality and pollution, the demand for air purification systems that utilize activated carbon fibers for effective VOC and odor removal has been on the rise.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35B2152
[email protected]
USA +1 351-333-4748